Zobrazeno 1 - 10
of 256
pro vyhledávání: '"I. Johannessen"'
Autor:
I. Kokki, D. Smith, P. Simmonds, S. Ramalingam, L. Wellington, L. Willocks, I. Johannessen, H. Harvala
Publikováno v:
New Microbes and New Infections, Vol 10, Iss C, Pp 6-12 (2016)
Acute viral hepatitis affects all ages worldwide. Hepatitis E virus (HEV) is increasingly recognized as a major cause of acute hepatitis in Europe. Because knowledge of its characteristics is limited, we conducted a retrospective study to outline dem
Externí odkaz:
https://doaj.org/article/a4148f7762414b229511ffc3bbfaa22f
Autor:
Katrine Heger, Caroline Lund, Margrete Larsen Burns, Marit Bjørnvold, Erik Sætre, Svein I. Johannessen, Cecilie Johannessen Landmark
Publikováno v:
Epilepsia Open, Vol 5, Iss 3, Pp 432-441 (2020)
Abstract Objective Dravet syndrome is a developmental and epileptic encephalopathy characterized by severe and drug‐resistant seizures in early childhood, followed by developmental delay. The purpose of this study was to investigate aspects of phar
Externí odkaz:
https://doaj.org/article/caa4f57cd25b41f889fce74ab7eb9dec
Autor:
Meir Bialer, Svein I. Johannessen, Matthias J. Koepp, René H. Levy, Emilio Perucca, Piero Perucca, Torbjörn Tomson, H. Steve White
Publikováno v:
EpilepsiaREFERENCES. 63(11)
The Eilat Conferences have provided a forum for discussion of novel treatments of epilepsy among basic and clinical scientists, clinicians, and representatives from regulatory agencies as well as from the pharmaceutical industry for 3 decades. Initia
Autor:
Meir Bialer, Svein I. Johannessen, Matthias J. Koepp, René H. Levy, Emilio Perucca, Piero Perucca, Torbjörn Tomson, H. Steve White
Publikováno v:
EpilepsiaREFERENCES. 63(11)
The Sixteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVI) was held in Madrid, Spain on May 22-25, 2022 and was attended by 157 delegates from 26 countries representing basic and clinical science, regulatory agencies, and pharm
Autor:
Cecilie Johannessen Landmark, Heidrun Potschka, Elaine C. Wirrell, Jo M. Wilmshurst, Svein I. Johannessen, Stéphane Auvin, Dorothée G.A. Kasteleijn-Nolst Trenité
Publikováno v:
Epilepsia
Developmental and epileptic encephalopathies (DEEs) are among the most chal- lenging of all epilepsies to manage, given the exceedingly frequent and often severe seizure types, pharmacoresistance to conventional antiseizure medications, and nu- merou
Autor:
C. F. Rowlatt, M. A. J. Chaplain, D. J. Hughes, S. H. Gillespie, D. H. Dockrell, I. Johannessen, R. Bowness
Individual responses to SARS-CoV-2 infection vary significantly, ranging from mild courses of infection that do not require hospitalisation to the development of disease which not only requires hospitalisation but can be fatal. Whilst many immunologi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::999dd8a9f73246654b66e9e66a49723c
https://doi.org/10.1101/2022.05.06.490883
https://doi.org/10.1101/2022.05.06.490883
Autor:
Meir Bialer, Svein I. Johannessen, Matthias J. Koepp, René H. Levy, Emilio Perucca, Piero Perucca, Torbjörn Tomson, H. Steve White
Publikováno v:
Epilepsia. 61:2365-2385
The Fifteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XV) was held as a fully virtual conference from July 27 to July 30, 2020 for the sessions on drugs, and on August 3, 2020 for the sessions on devices. A total of 534 delegat
Autor:
René H. Levy, Emilio Perucca, Meir Bialer, Matthias J. Koepp, Torbjörn Tomson, H. Steve White, Piero Perucca, Svein I. Johannessen
Publikováno v:
Epilepsia
Since 1992, the Eilat Conferences have provided a forum for all stakeholders in the epilepsy community to appraise the latest data on new antiepileptic drugs and emergency seizure treatments, including, in recent years, updates on progress with the d
Autor:
Cecilie Johannessen Landmark, Katrine Heger, Marit Bjørnvold, Svein I. Johannessen, Caroline Lund, Margrete Larsen Burns, Erik Sætre
Publikováno v:
Therapeutic Drug Monitoring. 42:744-753
The use of therapeutic drug monitoring (TDM) for antiseizure medications (ASMs) may contribute to treatment optimization in individual patients. This study included patients with Dravet syndrome as they often require close monitoring because of polyp
Autor:
Cecilie Johannessen Landmark, Caroline Lund, Svein I. Johannessen, Erik Sætre, Katrine Heger, Marit Bjørnvold, Margrete Larsen Burns
Publikováno v:
Epilepsia Open, Vol 5, Iss 3, Pp 432-441 (2020)
Epilepsia Open
Epilepsia Open
Objective: Dravet syndrome is a developmental and epileptic encephalopathy characterized by severe and drug-resistant seizures in early childhood, followed by developmental delay. The purpose of this study was to investigate aspects of pharmacologica